ViroCyt and I&L Biosystems Launch Virus Counter® 3100 at the World Vaccine Congress in Brussels

October 2, 2014 ViroCyt, LLC, the leader in rapid virus quantification, announced today that, in partnership with I&L Biosystems GmbH, it is formally launching the Virus Counter® 3100 in Europe at the World Vaccine Congress to be held October 13-15 in Brussels, Belgium. “The Virus Counter 3100 is the marquee analytical tool for quickly quantifying viruses, and we see exceptional …

New Rapid Virus Counter® System Introduced at World Vaccine congress

March 25, 2015 ViroCyt, LLC, the leader in rapid virus quantification, announced today the introduction of the next generation Virus Counter at the World Vaccine Congress being held in Washington, DC.  The Virus Counter technology has already been adopted by the leading companies in the fields of viral vaccine development and therapeutic protein expression.  The new system known as the …